Abstract
Dihydropyrimidine dehydrogenase (DPD) is a pyrimidine salvage enzyme responsible for degradation of thymine, which is produced from thymidine by thymidine phosphorylase (TP). Our purpose was to determine the relationship between DPD, cell proliferation and TP expression in human endometrium. We examined DPD gene expression using reverse transcription-polymerase chain reaction, DPD protein levels using enzyme-linked immunosorbent assay, and DPD protein localization using immunohistochemistry in 58 normal endometria and 28 endometrial cancers. DPD gene expression was then related to the proliferating cell nuclear antigen index and to TP gene expression. DPD gene expression, which was correlated with DPD protein level, was relatively stable throughout various menstrual phases but was significantly elevated in postmenopausal status. It was significantly lower in endometrial cancer than in normal endometrium. Localization analysis revealed that DPD protein was located primarily in epithelial cells, but was also present in stromal cells. DPD gene expression correlated inversely with the PCNA index. TP gene expression pattern contrasted with that of DPD in postmenopausal and malignant endometrium. A high ratio of TP to DPD gene expression was significantly more frequent in endometrial cancer than in normal endometrium in any menstrual phase. DPD may act cooperatively with TP to affect cell function by maintaining the pyrimidine nucleotide pool balance in normal and malignant endometrium.
Similar content being viewed by others
References
Brown NS, Bicknell R (1998) Thymidine phosphorylase, 2-deoxy-d-ribose and angiogenesis. Biochem J 334:1–8
Canellakis ES (1956) Pyrimidine metabolism-enzymatic pathways of uracil and thymidine degradation. J Biol Chem 221:315–322
Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K, Ishitsuka H (1993) Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32:333–338
Fink RM, Fink K, Henderson RB (1955) Beta-amino acid formation by tissue slices incubated with pyrimidines. J Biol Chem 201:349–355
Fujimoto J, Ichigo S, Sakaguchi H, Hirose R, Tamaya T (1998) Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle. Mol Hum Reprod 4:509–513
Fujiwaki R, Hata K, Iida K, Koike M, Miyazaki K (1998) Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. Gynecol Oncol 68:247–252
Fujiwaki R, Hata K, Iida K, Maede Y, Koike M, Miyazaki K (1999) Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis. J Clin Pathol 52:598–603
Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K (2000) Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 18:3946–3951
Fujiwaki R, Hata K, Nakayama K, Moriyama M, Iwanari O, Katabuchi H, Okamura H, Sakai E, Miyazaki K (2002) Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes. Int J Cancer 99:328–335
Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ (1997) The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57:570–572
Ho DH, Townsend L, Luna MA, Bodey GP (1986) Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate. Anticancer Res 6:781–784
Iltzsch MH, el Kouni MH, Cha S (1985) Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24:6799–6807
Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W, Heldin CH (1989) Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338:557–562
Ishikawa T, Sekiguchi F, Fukase Y, Sawada N, Ishitsuka H (1998) Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. Cancer Res 58:685–690
Jiang W, Lu Z, He Y, Diasio RB (1997) Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3:395–399
Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S (1998) Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 253:797–803
McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, Koruth M, Cassidy J (1998) Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77:461–465
Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL, Bicknell R (1995) Thymidine phosphorylase in angiogenic and promotes tumor growth. Proc Natl Acad U S A 92:998–1002
Mori K, Hasegawa M, Nishida M, Toma H, Fukuda M, Kubota T, Nagasue N, Yamana H, Hirakawa-YS Chung K, Ikeda T, Takasaki K, Oka M, Kameyama M, Toi M, Fujii H, Kitamura M, Murai M, Sasaki H, Ozono S, Makuuchi H, Shimada Y, Onishi Y, Aoyagi S, Mizutani K, Ogawa M, Nakao A, Kinoshita H, Tono T, Imamoto H, Nakashima Y, Manabe T (2000) Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. Int J Oncol 17:33–38
Noyes RW, Hertig AT, Rock J (1955) Dating the endometrial biopsy. Fertil Steril 1:3–25
Naguib FN, el Kouni MH, Cha S (1985) Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45:5405–5412
Okabe H, Arakawa K, Takechi S, Fukushima M (2000) Expression of recombinant human dihydropyrimidine dehydrogenase and its application to the preparation of anti-DPD antibodies for immunohistochemical detection. Jpn J Cancer Chemother 27:891–898
Osuga Y, Toyoshima H, Mitsuhashi N, Taketani Y (1995) The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period. Hum Reprod 10:989–993
Queener SF, Morris HP, Weber G (1971) Dihydrouracil dehydrogenase activity in normal, differentiating, and regenerating liver and hepatomas. Cancer Res 31:1004–1009
Terashima M, Fujiwara H, Takagane A, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Oyama K, Takahashi M, Saito K (2002) Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. Eur J Cancer 38:2375–2381
Tuchman M, Ramnaraine ML, O'Dea RF (1985) Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase. Cancer Res 45:5553–5556
Tuchman M, O'Dea RF, Ramnaraine ML, Mirkin BL (1988) Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors. J Clin Invest 81:425–430
Zhang L, Mackenzie IZ, Rees MC, Bicknell R (1997) Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 138:4921–4930
Acknowledgements
This work was supported by a Grant-in-Aid (No. 13770917) from the Japan Society for the Promotion of Science. We thank Mr. Mikio Koike, Laboratory Medicine and Central Clinical Laboratory, Shimane Medical University, for providing paraffin-embedded tissues and Miss Taeko Yamada, Department of Obstetrics and Gynecology, Shimane Medical University, for her management of medical records.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujiwaki, R., Iida, K., Nakayama, K. et al. Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase. Virchows Arch 443, 672–677 (2003). https://doi.org/10.1007/s00428-003-0866-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-003-0866-3